Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis

Published:2022-08 Issue:8 Volume:4 Page:100501
ISSN:2590-0595
Container-title:Kidney Medicine
language:en
Short-container-title:Kidney Medicine

Author:

Caster Dawn J.^ORCID,Magalhaes Barbara,Pennese Natali,Zaffalon Andrea,Faiella Marina,Campbell Kirk N.,Radhakrishnan Jai,Tesar Vladmir,Trachtman Howard

Publisher

Elsevier BV

Subject

Nephrology,Internal Medicine

Reference105 articles.

1. Focal segmental glomerulosclerosis;Rosenberg;Clin J Am Soc Nephrol,2017

2. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach;De Vriese;J Am Soc Nephrol,2018

3. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults;Braun;Cochrane Database Syst Rev,2008

4. KDIGO 2021 clinical practice guideline for the management of glomerular diseases;Kidney Int,2021

5. Treatment strategies of adult primary focal segmental glomerulosclerosis: a systematic review focusing on the last two decades;Beer;BioMed Res Int,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating FSGS-like injury in zebrafish larvae by nifurpirinol: efficacy and molecular insight;American Journal of Physiology-Renal Physiology;2024-09-01

2. How Stem and Progenitor Cells Can Affect Renal Diseases;Cells;2024-08-30

3. Management of focal segmental glomerulosclerosis in resource-limited regions;Pediatric Nephrology;2024-06-19

4. Novel Pathogenic Mutation of P209L in TRPC6 Gene Causes Adult Focal Segmental Glomerulosclerosis;Biochemical Genetics;2024-02-05

5. Clinicopathological Outcomes in Focal Segmental Glomerulosclerosis: A Retrospective Cohort Study;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024